CONTACT
ABOUT ABBOTT
cardiovascular
MY ACCOUNT

Xience™ Family of Drug Eluting Stents

THE WORLD'S LEADING DRUG-ELUTING STENTS (DES), WITH UNPARALLELED CLINICAL OUTCOMES1

Xience™ drug-eluting stents
Xience™ drug-eluting stents
Xience™ drug-eluting stents

     

            XIENCE™ SIERRA

Optimal Deliverability

Optimal Deliverability with XIENCE Skypoint™ Stent

Design elements with a proven ability to deliver with previous generations of XIENCE™ Stents, provide optimal deliverability for interventional cardiologists (ICs) encountering challenging lesions.

     

Catheter Enhancements

Unlike prior generations of XIENCE™ Stent, XIENCE Skypoint™ Stent has a seamless one-piece catheter shaft that optimizes pushability.2 In addition, the guide wire notch profile is reduced by 0.001”.3

Skypoint Stent

Optimal Deliverability

Data reveal optimal deliverability with XIENCE Skypoint™ Stent. This compares favorably with XIENCE Sierra™ Stent.4

Deliverability with XIENCE Skypoint Stent is 11% higher compared to XIENCE Sierra Stent.

Better Stent Retention

High stent retention helps prevent dislodgement and help ensure safe crossing, even when treating complex lesions. Testing reveals that XIENCE Skypoint™ Stent retention rates are better than those of Synergy‡ and Resolute Onyx‡ DES, reaching statistical significance.5

XIENCE Skypoint Stent performs better in stent retention tests compared to Synergy and Resolute Onyx drug-eluting stents.

Lower Crossing Forces with XIENCE Skypoint™ Stent6

Lower crossing forces can also aid in optimizing stent deliverability. Note that XIENCE Skypoint™ Stent crossing forces are significantly lower than those of Synergy‡ and Resolute Onyx‡ DES.

The crossing forces with XIENCE Skypoint Stent are significantly lower compared to Synergy and Resolute Onyx DES.

When using the XIENCE Skypoint™ 48-mm Stent, the hypotube has a 33% increase in wall thickness.7

The crossing forces with XIENCE Skypoint Stent are significantly lower compared to Synergy and Resolute Onyx DES.

Optimal Push Efficiency with XIENCE Skypoint™ Stent8

Testing confirms better push efficiency, revealing a 5% improvement for XIENCE Skypoint™ Stent compared to XIENCE Xpedition™ Stent.
Push Efficiency–48mm stents

    

Abbott’s Coronary Intervention Portfolio

References

  1. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333. Palmerini T, et al. Lancet. 2013;379:1393-1402. Bangalore S, et al. Circulation. 2012;125:2873-2891. Bangalore S, et al. Circ Cardiovasc Interv. 2013;6(6):378-390. Pilgrim T, et al. Lancet. 2014;384:2111-2122. Pilgrim T, et al. Lancet. 2018;392:737-746. Data on file at Abbott.
  2. Data on file at Abbott—XIENCE Skypoint™ Stent compared with XIENCE Sierra™ Stent.
  3. Data on file at Abbott—XIENCE Skypoint™ Stent Product Specification.
  4. Tests performed and data on file at Abbott—3.0 x 18 mm or 3.0 x 20 mm stents tested using a simulated arterial model.
  5. Tests performed by and data on file at Abbott. XIENCE Skypoint™ Stent (3.0 x 18 mm) n=5, SYNERGY‡ (3.0 x 20 mm) n=5, Resolute Onyx‡ (3.0 x 18 mm) n=5.
  6. Tests performed by and data on file at Abbott. XIENCE Skypoint™ Stent (3.0 x 18 mm) n=5, SYNERGY‡ (3.0 x 20 mm) n=5, Resolute Onyx‡ (3.0 x 18 mm) n=5.
  7. Data on file at Abbott. Hypotube wall thickness information—XIENCE Skypoint™ Stent 0.004ʺ compared with XIENCE Xpedition™ Stent 0.003ʺ.
  8. Test performed by and data on file at Abbott. XIENCE Skypoint™ Stent compared with XIENCE Xpedition™ Stent – 3.0 x 48 mm stents tested.

MAT-2305700 V1.0

 

Abbott Logo

Information contained herein for distribution in Australia and New Zealand only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

Abbott Vascular division of Abbott Medical New Zealand Ltd, Grd Flr, Bldg. D, 4 Pacific Rise Mt Wellington, Auckland 1060 Tel: 0800 827 285

Abbott Vascular division of Abbott Medical Australia Pty Ltd, 299 Lane Cove Road, Macquarie Park NSW 2113, Tel: 1800 550 939

© 2024 Abbott. All Rights Reserved.

MAT-2105201 v6.0

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

 

Do you wish to continue and enter this website?

 MAT-2408064 V1.0